GGO-dominant PPLs Diagnosis Using CLE and ssRAB-guided Cryobiopsy

NANot yet recruitingINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
Lung Ground-Glass Opacity
Interventions
DIAGNOSTIC_TEST

CLE and ssRAB-guided cryobiopsy

All procedures are performed under general anesthesia with endotracheal intubation and mechanical ventilation. A conventional flexible bronchoscope is used to examine the subject's airway and clear the secretion. After the registration procedure is completed, the catheter of the ssRAB system is navigated to the target lesion. Cone beam computed tomography (CBCT) is used to confirm whether the target lesion has been reached. After that, an appropriate CLE probe is inserted. Right before CLE imaging, 2.5 ml of 10% fluorescein sodium is administered intravenously. CLE is then used to examine the target lesion. Based on real-time CLE imaging, the optimal biopsy location is identified and localized on the fluoroscopy. After CLE imaging, the CLE probe is retracted, followed by cryobiopsy at the same location under fluoroscopy guidance. Rapid on-site evaluation is available during the procedure to assess sample adequacy.

Trial Locations (1)

200030

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Chest Hospital

OTHER

NCT06910046 - GGO-dominant PPLs Diagnosis Using CLE and ssRAB-guided Cryobiopsy | Biotech Hunter | Biotech Hunter